Moderna Stock Price - MRNA

0.20 (0.67%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Moderna Inc MRNA NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
2.11 7.55% 30.05 27.95 31.09 28.37 27.94 00:00:02
Bid Price Ask Price Spread Spread % News
30.05 30.30 0.25 0.83% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
94,252 12,408,297 $ 29.51 $ 366,196,515 21,507,953 11.54 - 35.98
Last Trade Time Type Quantity Stock Price Currency
19:59:53 formt 100 $ 30.25 USD

Moderna Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 9.89B 329.00M $ -384.73M -1.54 - 306.59M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Moderna News

Loading Messages....

Latest MRNA Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MRNA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week29.2531.0924.3627.1010,726,7580.802.74%
1 Month23.3834.9819.3127.2418,893,0406.6728.53%
3 Months19.0235.9817.6825.7012,686,21911.0357.99%
6 Months16.2935.9813.5324.776,818,17113.7684.47%
1 Year20.0835.9811.5423.234,275,9119.9749.65%
3 Years22.0035.9811.5422.813,613,8338.0536.59%
5 Years22.0035.9811.5422.813,613,8338.0536.59%

Moderna Description

Moderna Inc is engaged in creating transformative medicines based on messenger RNA, or mRNA. It transfers the information stored in the genes to the cellular machinery that makes all the proteins required for life. The firm is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases. Its clinical trials include mRNA-1647, mRNA-1893, mRNA-4157, and mRNA-2416 among others.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.